Patient-reported pain and other symptoms as prognostic factors for overall survival (OS) in a phase III clinical trial of patients with advanced breast cancer. This is an ASCO Meeting Abstract from ...

Gardasil 4 is the most cost-effective HPV vaccine for women with HIV aged 18-45, reducing cervical cancer and genital warts significantly. ART adherence enhances the cost-effectiveness of HPV ...